As we begin to reopen Rush University Medical Center for elective procedures and in-person care, we are putting your safety first. For information about COVID-19, see the latest updates. Rush accepts donations to support our response effort, staff, and patients and families.

Excellence is just the beginning.

Translate

French German Italian Portuguese Russian

Data Collection Study on Patients Receiving a DRG Stimulator

Clinical Trial Title: 
A post-approval study to evaluate targeted SCS (DRG) stimulation for the management of moderate to severe chronic, intractable, pain of the lower limbs due to CRPS types I and II.
Clinical Trial Protocol ID: 
16052703
Clinical Trial Investigator Name: 
Timothy R. Lubenow, MD
Clinical Trial Protocol Description: 

Research study to collect data on patients who are receiving a DRG stimulator.

Clinical Trial Eligibility Criteria: 

In order to participate you must meet the following criteria:

  • Have a DRG stimulator implant scheduled.

You will be excluded from the study if any of the following criteria apply to you:

  • Do not have or are not planning on receiving a DRG stimulator.

This is a partial list of inclusion and exclusion criteria.

Clinical Trial Area: 
Pain Management
Contact Phone: 
(312) 942-2985
Contact Name: 
Sherry Robison